Perbedaan Brigit Biofarmaka Teknologi Tbk. dan SLJ Global Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan SLJ Global Tbk. diperdagangkan di Rp88 (kapitalisasi pasar 568,87 M, volume 24 jam 7,01 jt). Perbedaan utamanya: SLJ Global Tbk. jauh lebih besar — sekitar 3,4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan SLJ Global Tbk. lebih aktif diperdagangkan (7,01 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SULI | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 568,87 M |
Volume | 324 rb | 7,01 jt |
Lot | 3,24 rb | 70,07 rb |
Perputaran | 77,68 jt | 617,4 jt |
Harga Rata-rata | 239,75 | 88,11 |
Nilai Transaksi | 77,68 jt | 617,4 jt |
Harga Ekuilibrium Indikatif | 240 | 88 |
Volume Ekuilibrium Indikatif | 1 | 163 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT SLJ Global (the Company) was established under the name of PT. Sumalindo Lestari Jaya in the Republic of Indonesia based on Notarial Deed No. 10 dated April 14, 1980, of Rukmasanti Hardjasatya , S.H., as amended by Deed No. 1 dated June 3, 1980, of the same notary.
Selengkapnya di halaman SULI →